In mid-2019, Novacyt’s stock (AIM: NCYT; Euronext Growth: ALNOV) was trading at a fraction of its future value. Share Price | Novacyt

The date , fell in the wake of several major corporate actions that reshaped the company's financial health:

The core of its microbiology, hematology, and serology offerings.

In early 2019, the company successfully raised approximately €785,000 to fund this expansion, showing strong investor confidence despite its small-cap status at the time.